SCShi-Bo Cheng

Shi-Bo Cheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shi-Bo Cheng has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Capture and Culture of Circulating Tumor Cells Using a Biodegradable 3D Scaffold for Patient‐Derived Xenograft Construction

    by Yi‐Ke Wang, Ming Wang, Min Liu, Yi‐Jing Chen, Li‐Li Xu, Jin‐Ping Zhou, Fu‐Bing Wang, Shi‐Bo Cheng, Min Xie, Wei‐Hua Huang

    Patient‐derived xenograft (PDX) models constructed by noninvasively accessible circulating tumor cells (CTCs) serve as pivotal and invaluable tools for oncology research and precision medicine. However, the rarity of CTCs in blood and their limited proliferation ability present significant challenges for establishing patient CTC‐derived xenograft (CDX) models. In this study, a novel 3D cellulose scaffold is developed for efficient isolation and in situ culture of CTCs, with the aim of constructing CDX models. Characterized by a macroporous and flexible structure, the 3D cellulose scaffold achieves high‐efficiency CTC capture while maintaining cell viability. Its excellent biocompatibility and permeability further promote the rapid and in situ growth of CTCs. Importantly, the self‐supporting and biodegradable scaffold allows for direct implantation into immunodeficient mice without leaving any residual material. This 3D cellulose scaffold has been successfully employed to construct CDX models from breast cancer patients. The application of this platform may enhance our understanding of metastasis mechanisms and offer significant benefits for cancer therapy.

  • An integrated microfluidic chip for synchronous drug loading, separation and detection of plasma exosomes

    by Yu-Xin Zhang, Ming Wang, Li-Li Xu, Yi-Jing Chen, Shu-Ting Zhong, Ying Feng, Hai-Bo Zhang, Shi-Bo Cheng, Min Xie, Wei-Hua Huang

    A microfluidic chip integrating a 3D macroporous scaffold and magnetoresponsive electrode achieves exosome isolation, electrochemical detection, and doxorubicin loading, offering a seamless platform for analysis and therapeutic delivery.


  • Open Access

    Boron Clusters Escort Doxorubicin Squashing Into Exosomes and Overcome Drug Resistance

    by Yi‐Ru Bao, Yi‐Jing Chen, Xue‐Fan Deng, Yi‐Ke Wang, Yu‐Xin Zhang, Li‐Li Xu, Wei‐Hua Huang, Shi‐Bo Cheng, Hai‐Bo Zhang, Min Xie

    Exosome‐based drug delivery holds significant promise for cancer chemotherapy. However, current methods for loading drugs into exosomes are inefficient and cost‐prohibitive for practical application. In this study, boron clusters are mixed with doxorubicin (DOX) and exosomes, enabling the efficient encapsulation of DOX into exosomes through a superchaotropic effect. Exosomes loaded with DOX and boron clusters (EDB) exhibit superior permeability and the ability to deliver higher concentrations of DOX into DOX‐resistant breast cancer cells. Mechanistic analysis reveals that boron clusters form a supramolecular complex with DOX, which facilitates sustained drug release and effectively inhibits P‐glycoprotein‐mediated DOX efflux. As a result, EDB significantly enhance apoptosis in DOX‐resistant breast cancer cells and suppress tumor growth in cases where DOX alone is ineffective, thereby extending the survival of nude mice. In summary, boron clusters effectively facilitate the incorporation of DOX into exosomes and inhibit DOX efflux, offering a novel strategy to overcome DOX resistance.